Toby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma

Similar documents
Toby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma

Total body photography in high risk patients

Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc

SKIN CANCER. Most common cancer diagnosis 40% of all cancers

Identifying Skin Cancer. Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018

Know who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated

Finding Melanoma. Is not easy!

Know who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated

Melanoma and Dermoscopy. Disclosure Statement: ABCDE's of melanoma. Co-President, Usatine Media

Practical Tips for Caring for Melanoma Patients

Melanoma. Kaushik Mukherjee MD A. Scott Pearson MD

p16 Genetic Test Reporting Counseling Protocol Flip Chart

Contrast with Australian Guidelines A/Pr Pascale Guitera,

Clinical characteristics

VACAVILLE DERMATOLOGY

Dermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses.

Cutaneous Malignancies: A Primer COPYRIGHT. Marissa Heller, M.D.

Malignant Melanoma Early Stage. A guide for patients

Large majority caused by sun exposure Often sun exposure before age 20 Persons who burn easily and tan poorly are at greatest risk.

Protocol applies to melanoma of cutaneous surfaces only.

Dermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial

Mole mapping and monitoring. Dr Stephen Hayes. Associate Specialist in Dermatology, University Hospital Southampton

Cutaneous Melanoma: Epidemiology (USA) The Sentinel Node in Head and Neck Melanoma. Cutaneous Melanoma: Epidemiology (USA)

Melanoma. Consultation on draft guideline - stakeholder comments. Comments to be submitted before 5pm on Friday 13 March 2015

IT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY

Associate Clinical Professor of Dermatology MUSC

Management of Atypical Pigmented Lesions

David B. Troxel, MD. Common Medicolegal Situations: Misdiagnosis of Melanoma

Living Beyond Cancer Skin Cancer Detection and Prevention

Epithelial Cancer- NMSC & Melanoma

An Overview of Melanoma. Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center

WHAT DOES THE PATHOLOGY REPORT MEAN?

A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL

Updates on Melanoma: Are You Following the Latest Guidelines of Care? Jerry Brewer, MD

Learning Objectives. Tanning. The Skin. Classic Features. Sun Reactive Skin Type Classification. Skin Cancers: Preventing, Screening and Treating

Vernon K. Sondak. Department of Cutaneous Oncology Moffitt Cancer Center Tampa, Florida

Periocular Malignancies


1. Written information to patient /GP: fax ASAP to GP & offer copy of consultation letter.

MALIGNANT MELANOMA. Dr D. Tenea Department of Dermatology University of Pretoria

Teledermatology. Acne. What the primary care physician needs to know in the world of increased access

Skin Cancer. 5 Warning Signs. American Osteopathic College of Occupational and Preventive Medicine OMED 2012, San Diego, Monday, October 8, 2012 C-1

Multiple Primary Melanoma in a Thai Male: A Case Report

1. Opdivo + Ipilumimab is now the first line therapy for metastatic melanoma.

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

Melanoma: The Basics. What is a melanocyte?

Multispectral Digital Skin Lesion Analysis. Summary

Associate Professor Amanda Oakley. Professor H. Peter Soyer. Academic Dermatologist The University of Queensland Brisbane. Dermatologist Hamilton

Work-up/Follow-up: Baseline and Surveillance Studies for Cutaneous Melanoma Patients

Melanoma and Mimickers

Skin Malignancies. Presented by Dr. Douglas Paauw

Dr. Brent Doolan, BSc MBBS MPH

Cancer Council Australia Wiki Guidelines 2017

Melanoma Surgery Update James R. Ouellette, DO FACS Premier Health Cancer Institute Wright State University Chief, Surgical Oncology Division

Corporate Medical Policy

Regression 2/3/18. Histologically regression is characterized: melanosis fibrosis combination of both. Distribution: partial or focal!

They can develop anywhere on the skin and also inside the mouth. They can develop in normal skin or where there is an existing skin mole.

MELANOMA: HANDS-ON OR HANDS-OFF?

Diagnosis of Lentigo Maligna Melanoma. Steven Q. Wang, M.D. Memorial Sloan-Kettering Cancer Center Basking Ridge, NJ

المركب النموذج--- سبيتز وحمة = Type Spitz's Nevus, Compound SPITZ NEVUS 1 / 7

Technicians & Nurses Program

Dermatological Manifestations in the Elderly. Sanjay Siddha Staff Dermatologist UHN & MSH

Clinical Practice Guidelines

MELANOMA IN ADOLESCENTS AND YOUNG ADULTS

Melanoma Patients and the Sentinel Lymph Node (SLN) Procedure: An Oncologic Surgeon s Perspective

MAPK Pathway. CGH Next Generation Sequencing. Molecular Tools in Care of Patients with Pigmented Lesions 7/20/2017

Oliver J. Wisco, DO, FAAD Melanoma Specialist & Mohs Surgeon Bend Memorial Clinic

Dermoscopy: Recognizing Top Five Common In- Office Diagnoses

Malignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha

MELANOMA. Some people are more likely to get a m Melanoma than others:

Melanoma Underwriting Presented at 2018 AHOU Conference. Hank George FALU

Springer Healthcare. Staging and Diagnosing Cutaneous Melanoma. Concise Reference. Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone

NAACCR Webinar Series 1

Seventh Edition Staging 2017 Melanoma. Overview. This webinar is sponsored by. the Centers for Disease Control and Prevention.

Disclosures. I have no conflicts of interest to disclose

When Do I Consider Myself Cured?

Primary Cutaneous Melanoma Pathology Reporting Proforma DD MM YYYY. *Tumour site. *Specimen laterality. *Specimen type

Skin Malignancies Non - Melanoma & Melanoma Marilyn Ng, MD Dept. of Surgery M&M Conference Downstate Medical Center July 19, 2012

Talk to Your Doctor. Fact Sheet

Skin Cancer A Personal Approach. Dr Matthew Strack Dunedin New Zealand

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Practical Management of Atypical Melanocytic Lesions

Advances in Surgical Management of Primary Melanoma: Identifying Patients Who Need More than Conventional Wide Local Excision

Department of Dermatology, Queen Margaret & Victoria Hospitals

Management of Cutaneous Melanoma of the Head and Neck and a bit about SCCA/BCC. Irvin Pathak

Dermatopathology. Dr. Rafael Botella Estrada. Hospital La Fe de Valencia

Skin Cancer 101: Diagnosis and Management of the Most Common Cancer

Which melanoma patients benefit from genetic testing?

Oncology General Principles L A U R I E S I M A R D B R E A S T S U R G I C A L O N C O L O G Y F E L L O W D E C E M B E R

Genetic Testing: When should it be ordered? Julie Schloemer, MD Dermatology

Topics for Discussion. Malignant Melanoma. Surgical Treatment. Current Treatment of Cutaneous Melanoma 5/17/2013. Lymph Regional nodes:

This is a repository copy of Easily missed? Amelanotic melanoma. White Rose Research Online URL for this paper:

Disclosures. Melanoma and Non melanoma Skin Cancer: What You Need to Know. I have no conflicts of interest to disclose

Metastatic Melanoma. Cynthia Kwong February 16, 2017 SUNY Downstate Medical Center Department of Surgery Grand Rounds

MELANOMA. 4 Fitzroy Square, London W1T 5HQ Tel: Fax: Registered Charity No.

Cancer Reporting for Dermatologists. Florida Department of Health Florida Cancer Data System. March 9, Agenda

Accuracy of Malignant Melanoma Detection in the Community

You Are Going to Cut How Much Skin? Locoregional Surgical Treatment. Justin Rivard MD, MSc, FRCSC September 21, 2018

SURGERY OF THE HAND. Nodular Melanoma on the Tip of the Thumb INTRODUCTION CASE REPORT. Su Hyun Choi, Hong Bae Jeon, Ja Hea Gu

Transcription:

Distinguishing Pigmented Skin Lesions and Melanoma Toby Maurer, MD University of California, San Francisco Epidemiology of Melanoma Lifetime risk of an American developing melanoma 1935: 1 in 1500 1980: 1 in 250 2002: 1 in 68 Melanoma Statistics Not an old person s disease 1 in 4 persons w/melanoma are under 40 Most common cancer in women ages 25-29 2nd most common cancer for women age 30-34 1

Risk Factors Red/blond hair Family history of melanoma Sun exposure in childhood/intermittant sun exposure Multiple nevi-typical and atypical in fair-skinned persons Melanoma- Miller AJ-NEJM July 2006-good review re: nevus to melanoma-what it takes Survival In 1940 s 5 year survival was 40%, now 90% Survival assoc. with tumor thickness-early detection is what has changed statistic not the treatment Melanoma Survival Rates 10-Year Survival Rates of Patients Tumor thickness (mm) No ulceration Ulceration 0.01 to 1.00 92% 69% 1.10 to 2.00 78% 63% 2.01 to 4.00 60% 53% > 4.00 55% 36% 2

Specific Types of Melanoma Lentigo maligna Nodular Melanoma Acral Melanoma Amelanotic Melanoma 3

4

How do we increase our chances of finding thin melanomas Full body exam on everybody?-not enough evidence to support Screening for skin cancer: an update from US preventive services task force: Annals of Internal Med 2009 Feb-Wolff T, et al. Concentrate on high risk folks and incorporate skin exam into physical exam-men 50 and olderlook at their backs Factors Associated with physician discovery of early melanoma in middle-aged and older men. Arch Dermatol 2009 Apr Geller AC et al. Ask these questions: 1) Personal or family history of melanoma? 2) History of atypical nevus that has been removed? 3) Presence of new or changing mole- i.e. change in size or color? Melanoma Melanoma may be INHERITED or occur SPORADICALLY 10% of melanomas are of the INHERITED type Familial Atypical Multiple Mole- Melanoma Syndrome (FAMMM) 5

Risk Factors for Sporadic (Nonhereditary) Melanoma Numerous normal nevi, some atypical nevi Sun sensitivity, excessive sun exposure 6

Clinical Features of FAMMM Often numerous nevi (30-100+) Nevi > 6mm in diameter New nevi appear throughout life (after age 30) Nevi in sun-protected areas (buttocks, breasts of females) Family history of atypical nevi and melanoma CDKN2A best understood of hereditary genes-67% lifetime risk of developing melanoma Testing not recommended outside research trials-penetrance not understood, role of outside factors, risk of other cancers not clearly defined, meaning of negative test Take all nevi off-no to melanotomies Look for signature nevi and then identify ugly duckling-strategies for early melanoma detection Approaches to the patient with nevi-jaad may 2009 Goodson A and Grossman D 7

If not sure: Measure and see pt back in 3-6 months for reevaluation!! Risk Categories (Lifetime Risk) Very low risk: pigmented races (Latino,African American,Asian,etc.) Low risk: Caucasian = 1% Intermediate risk: Caucasian w/additional risk factors = 2% - 10% High risk: FAMMM Syndrome up to 100% Prevention Self examination/spousal exam for low-risk individuals Self examination/spousal exam and regular physician examination (yearly to every several years) for intermediate risk individuals Self examination and examination by a dermatologist every 3-12 months for FAMMM kindred 8

Tools to improve the Art Photography- available at pigmented nevus centers Involves mapping of nevi, far and close up photos Set of photos for pt and provider About $200.00 Dermoscopy-magnified view of lesion-a science being developed and validated-needs lots of training; better developed in Europe Confocal microscopy-looking at lesions in the human at the bedside Genomic Hybridization-used by pathologists Differential Diagnosis Seborrheic keratosis Nevus, blue nevus, halo nevus Solar (senile) lentigo Pigmented BCC Dermatofibroma 9

10

11

How to Diagnose If melanoma is suspected, an excisional biopsy is recommended If the lesion is too large to excise, an incisional biopsy may be done to include any nodules, dark-black areas and white areas Why Excisional Biopsy? The diagnosis and prognosis of melanoma is dependent on the depth of the lesion Send your pathologist the whole thing Dermatopathologist or general pathologist? 12

What to do if Melanoma Staging workup for melanomas > 0.7 mm in depth Re-excise all melanomas with wider margins What to Do if Melanoma Dx Depth is key < 0.7 *mm *- Close clinical f/u and labs > 0.7 *mm* - CT scans of chest, pelvis, MRI/PET scan brain & sentinel nodes to stage Now also looking at mitoses to determine work-up Melanoma center at least once (or call for latest guidelines) Prognositc Importance of Sentinel Lymph Node in Thin Biopsies of Melanoma- Ranier JM et al. Ann Surg Oncol July 2006 Management of Cutaneous Melanomas-Tsao, et al. NEJM Sept 2004-good review If Melanoma: Re-excise area with larger surgical margins: size of reexcision dependent on the original depth of melanoma Original melanoma in-situ-excise 0.5 cm margin Original melanoma < 1 mm-excise 1.0 cm margin Original melanoma >1 mm-excise 2.0 cm margin Coordinate with surgeon in the know and someone who can do nuclear scan/sentinal node at time of the reexcision if indicated. Primary care follow-up For the first two years after diagnosis-see patient back q 6 months for total body exam Looking for local recurrence, in-transit metastases, lymph node involvement and second melanomas. Q yr CBC, LFT s including LDH for lymph node involvement or ulcerative lesion CXray-controversial 13

Follow-up for Melanomas Second melanomas 1% after 1 year, 2% at 5 yrs, 3% at 10 yrs and 5% at 20 yrs-regular f/u for LIFE (Cancer 97,2003) Developing new risk trees for patients with thinner melanomas Also look for non-melanoma skin cancer and non- Hodgkin s lymphoma (higher risk is those who had primary melanoma) Melanoma risk is 5 x s higher in renal transplant recipients New Directions in Therapy Surgical excision is our therapy Very little to offer re: metastatic disease-6-9 month survival. Current chemo extends life to 1.3 yrs Rational therapy that targets genes and interrupts signalling pathways for metastases Chudnovsky Y, Khavari P, Adams A. J. Clin Investigations April 2005 Special Cases Genital pigmented lesions Congenital nevi Pregnancy Genital Pigmented Lesions Follow the same rules as other pigmented lesions 15% had family history of melanoma 14

Congenital Nevi < 1 cm - 1% Lifetime risk of melanoma 1-5 cm - Unknown risk > 5 cm - 10% Lifetime risk Have congenital nevi evaluated once by a dermatologist Pregnancy Nevi change during pregnancy New ones appear Should people who have had melanoma get pregnant? Depends on depth of melanoma Call Central Melanoma Center for advice 15

16

17

18